Radiography
Volume 13, Supplement 1 , Pages e90-e98, December 2007

A pilot study to investigate the effect of a hydration regime upon immediate and 24h delayed MRI contrast agent reactions

  • William Bailey

      Affiliations

    • Medical Imaging, Leighton Hospital, Mid Cheshire Hospital Trust, Middlewich Road, Crewe, Cheshire CW1 4QJ, UK
    • Present address: Cross Section Imaging, Manchester Royal Infirmary, Oxford Road, Manchester, UK.
    • Corresponding Author InformationCorresponding author. Tel.: +44 1270 612505.
    • ,
  • Gill Marshall

      Affiliations

    • Chair of Faculty Academic Standards International Projects Leader, Faculty of Health and Social Care, St. Martin's College, Lancaster LA1 3JD, UK
    • ,
  • Jacqui Coals

      Affiliations

    • Medical Imaging, Leighton Hospital, Mid Cheshire Hospital Trust, Middlewich Road, Crewe, Cheshire CW1 4QJ, UK
    • Present address: Cross Section Imaging, Manchester Royal Infirmary, Oxford Road, Manchester, UK.

Received 4 December 2006; accepted 6 February 2007.

Abstract 

Purpose

Adverse reaction rates to gadolinium based magnetic resonance imaging (MRI) contrast agents which occur immediately post-injection are well documented. However little research has investigated delayed reaction rates (i.e. 30min–24h). This study evaluated the rate of immediate and delayed adverse reaction rates to a gadolinium based MRI contrast agent (Dotarem®) and investigated the effect of a hydration regime on the rate of adverse events.

Method

Fifty-eight patients received no preparation, prior to administration of the contrast agent, whilst another 58 underwent a hydration protocol. The patients had their answers to a questionnaire recorded immediately after the scanning procedure and also via a follow-up telephone call 24h later.

Results

In the unprepared group 9 patients (15.5%) experienced immediate adverse events, i.e. within 0–30min, whereas 24 (41.4%) experienced delayed reactions (30min–24h) after administration of the contrast agent. In the hydrated patient group 6 (10.3%) experienced an immediate adverse event, whilst 8 (13.7%) experienced delayed events post-injection. The difference in the total reaction rates for the unprepared and hydrated groups was statistically significant for immediate and delayed reactions. The difference in the rates of delayed headache, nausea, dizziness and problems with the injection site, for the unprepared and hydrated groups was statistically significant.

Conclusion

An oral hydration regime administered to patients, both before and after MRI contrast agent administration significantly reduced the total number of immediate and delayed reactions. It also significantly reduced delayed headache, nausea, dizziness and problems at the injection site. Whilst this pilot study had methodological shortcomings, the strength of the relationship demonstrated are worthy of further investigation.

Keywords: Magnetic resonance imaging, Contrast agent, Dotarem®, Adverse reactions, Contrast induced nephropathy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-8174(07)00013-2

doi:10.1016/j.radi.2007.02.005

Radiography
Volume 13, Supplement 1 , Pages e90-e98, December 2007

Article Tools

* Image Usage & Resolution